Navigation Links
Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells

MIAMI, FL (PRWEB) February 26, 2013

Dr. Carlos Szajnert, principle to cutting-edge facility in South Florida that is specialized in Obstetrical and Gynecology, announced today he would play a role in further advancing the awareness of cord blood stem cell benefits in the community.

Dr. Szajnert’s specialties include; abdominal ultrasounds, cesarean section, endoscopic therapy endoscopy, estrogen replacement therapy, hormonal therapy, hormone replacement therapy, hysterectomy, laparoscopy, ovarian ablation, pelvic laparoscopy and uterine ablation.

For years now, Dr. Szajnert has been the leading and preferred OB/GYN for most Latin American parents that are expecting a baby in South Florida. Especially those who are seeking to give birth in Miami from Venezuela, Chile, Colombia, Costa Rica, Dominican Republic, Guatemala, Honduras, Panama, Peru, and Puerto Rico.

"Out of all the specialties in medicine, obstetrics is the most beautiful and gratifying. One of the most special moments in any family is the birth of a baby. It is a privilege to be able to share this moment with that family. We feel very proud to be part of this unique experience. Our goal is to provide the patient and her family comfort and peace of mind. During the prenatal visits we build a special relationship with our patients where they build confidence and security with our facility. Our team makes the patient feel as if she was part of our family", said Dr. Carlos Szajnert.

Dr. Szajnert, also performs collections of umbilical cord bloods to be processed and stored at local cord blood laboratories when requested by his patients. Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specialized bank. The cord blood can later be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match. Cord blood banking is regulated by the U.S. Food & Drug Administration and each year more and more parents have chosen to save their children’s cord blood stem cells. “Because of the impact cord blood therapies have in an individual’s life, I believe cord blood preservation will become exceptionally common among expecting parents”

“This opportunity permits us to further educate our community to ensure everyone is given the best and most current information on preserving cord blood stem cells, it will allow patients of ours or a family member’s life to be potentially saved”, added Dr. Szajnert’s Office Manager, Eliana Szajnert.

Alongside his commitment to educating and providing medical treatments to his patients, Dr. Carlos Szajnert is always on the forefront of therapeutic procedures as a Premier Obstetrician and Gynecologist in South Florida.

For more information on Dr. Carlos Szajnert’s practice and specialties, please feel free to visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Top Contenders For the First Annual 2012 Fright Night Awards Presented By Cancer Bites Announced
2. $1 Million Global B.R.A.I.N. Prize Announced by Israel Brain Technologies
3. Companies Selected to Present at AdvaMed 2012 Announced
4. Life Science Professionals: Annual Career Fair Announced
5. 2011-2012 Michael E. DeBakey Journalism Award Winners Announced
6. China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO
7. Statewide Network of Angel Investor Groups Announced in Alabama
8. Complete Agenda Announced for 11th Annual Patient Adherence Forum
9. Fifth Cycle of Probiotics & Microbiota Research Grant Announced
10. 2011 ErgoExpo Attendees Choice Award Winners Announced During Sold Out Expo; Exhibitor Renewal for 2012 Hits 96% and Counting
11. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
Post Your Comments:
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... The Global Genomics Industry ... and in-depth study on the current state of ... ) , The report provides ... classifications, applications and industry chain structure. The Genomics ... including development trends, competitive landscape analysis, and key ...
(Date:11/24/2015)... Cepheid (NASDAQ: CPHD ) today announced ... conference, and invited investors to participate via webcast. ... December 1, 2015 at 11.00 a.m. Eastern Time ... December 1, 2015 at 11.00 a.m. Eastern Time ... York, NY      Tuesday, December 1, 2015 at ...
Breaking Biology Technology:
(Date:11/30/2015)... , Nov. 30, 2015  BIOCLAIM announced ... finalist in this year,s Fierce Innovation Awards:  Healthcare Edition, ... FierceHealthIT , FierceHealthcare , ... as a finalist in the category of "Privacy ... --> --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/20/2015)... Connecticut , November 20, 2015 ... authentication company focused on the growing mobile commerce market ... CEO, Gino Pereira , was recently interviewed on ... interview will air on this weekend on Bloomberg ... Latin America . --> NXTD ) ("NXT-ID" ...
Breaking Biology News(10 mins):